30 results
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
, the audit committee reviews our policies with respect to risk assessment, risk management, loss prevention and regulatory compliance. Oversight by the audit … of director’s assessment of our Chief Executive Officer’s roles and responsibilities within our company, there are significant compensation differentials
8-K
GOSS
Gossamer Bio Inc
25 Apr 22
Results of Operations and Financial Condition
8:14am
relative to placebo at week 12. An assessment of available 36-week data showed no meaningful improvement on efficacy endpoints.
The safety
8-K
EX-99.1
7pfboli
9 Aug 21
Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
4:27pm
8-K
EX-99.2
q1aqz2 ab
14 May 19
Gossamer Bio Announces First Quarter 2019 Financial Results
7:31am
8-K
EX-99.1
6ugbek5kmrtud
20 Jul 23
Interim TORREY OLE Update and PROSERA Phase 3 Design July 2023
7:50am
8-K
EX-99.1
ir7818m98vbq71
6 Dec 22
Other Events
7:36am
10-K
lf3jtfb0djo8kq9x5ds
22 Mar 19
Annual report
4:45pm
DEF 14A
y4mrpu
30 Apr 19
Definitive proxy
4:04pm
DRS
20v0dw5kq4ymtw40xxou
11 Oct 18
Draft registration statement
12:00am
DRS/A
x2vw88iamxab er17y
29 Nov 18
Draft registration statement (amended)
12:00am
S-1
EX-10.15
1fg9jgz9s77
21 Dec 18
IPO registration
4:39pm